|
Market Closed -
Bombay S.E.
03:32:23 14/08/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 79.87 INR | -4.06% |
|
-4.23% | +48.93% |
| Market Cap | 11Cr 11.72L 10.13L 10L 9L 16.27L 16.54L 1.11Cr 43.59L 5.61Cr 44.01L 43.06L 19Cr | P/E 2024 |
19.5x | P/E 2025 | 36.8x |
|---|---|---|---|---|---|
| Enterprise Value | 6.3Cr 7L 6L 5L 5L 9L 9L 62.66L 24.5L 3.16Cr 24.74L 24.2L 10Cr | EV / Sales 2024 |
0.43x | EV / Sales 2025 | 2.04x |
| Free-Float |
31.44% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -4.06% | ||
| 1 week | -4.23% | ||
| Current month | -2.60% | ||
| 1 month | +7.66% | ||
| 3 months | +75.54% | ||
| 6 months | +58.85% | ||
| Current year | +48.93% |
| 1 week | 76.15 |  | 84.5 |
| 1 month | 74.1 | | 85.99 |
| Current year | 39.31 | | 87.91 |
| 1 year | 36.11 | | 87.91 |
| 3 years | 35.2 | | 88.7 |
| 5 years | 15.55 | | 88.7 |
| 10 years | 4.8 | | 88.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 74 | - | |
Ganesh Chitte
DFI | Director of Finance/CFO | - | 20/05/2019 |
Falguni Kumawat
CMP | Compliance Officer | - | 01/12/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 74 | 26/11/1990 | |
| Director/Board Member | 33 | 08/08/2024 | |
| Director/Board Member | 76 | 08/08/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.06% | -4.23% | +84.54% | +116.39% | 21.04L | |
| -0.10% | -0.77% | +17.58% | +70.16% | 4.84TCr | |
| -3.26% | -5.31% | +53.19% | +117.23% | 3.97TCr | |
| -0.60% | -0.94% | -7.29% | +17.35% | 1.23TCr | |
| -2.75% | +1.88% | +14.81% | +76.92% | 1.18TCr | |
| -0.19% | -0.38% | +30.40% | +135.91% | 906.17Cr | |
| +1.56% | +5.52% | +23.46% | +39.78% | 756.57Cr | |
| +0.52% | +2.08% | +40.75% | -12.45% | 717.59Cr | |
| -0.07% | +1.72% | +13.39% | +190.65% | 684.21Cr | |
| -2.51% | -3.14% | -27.46% | +24.20% | 576.86Cr | |
| Average | -1.15% | +1.51% | +24.34% | +77.61% | 1.49TCr | |
| Weighted average by Cap. | -1.18% | +1.03% | +25.08% | +81.16% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.03Cr 7L 6L 6L 5L 10.2L 10.37L 69.91L 27.33L 3.52Cr 27.6L 27L 12Cr | 6.53Cr 7L 6L 6L 5L 9L 10L 64.92L 25.38L 3.27Cr 25.63L 25.07L 11Cr |
| Net income | 48.67L 50.9T 43.96T 41.31T 37.57T 70.63T 71.8T 5L 2L 24.37L 2L 2L 80.99L | 49.66L 51.93T 44.85T 42.15T 38.33T 72.07T 73.26T 5L 2L 24.87L 2L 2L 82.64L |
| Net Debt | -6.43Cr -7L -6L -5L -5L -9L -9L -63.95L -25L -3.22Cr -25.25L -24.7L -11Cr | -4.91Cr -5L -4L -4L -4L -7L -7L -48.82L -19.09L -2.46Cr -19.28L -18.86L -8.17Cr |
Employees
65
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/26/14 | ₹79.87 | -4.06% | 309 |
| 13/26/13 | ₹83.25 | +2.15% | 2,500 |
| 12/26/12 | ₹81.50 | +2.28% | 15,244 |
| 11/26/11 | ₹79.68 | +0.01% | 246 |
| 10/26/10 | ₹79.67 | -4.47% | 756 |
- Stock Market
- Stocks
- COLINZ6 Stock
Select your edition
All financial news and data tailored to specific country editions
